Company profile
UK company 09812865, incorporated on 7 October 2015.
Home - Ablatus Therapeutics
Ablatus Therapeutics Limited is a UK company with status Liquidation founded in 2015 based in Yorkshire and the Humber.
Company number 09812865
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Aug 2020 to 31 Jul 2022
Colorectal cancer is the second most common cause of cancer-related deaths in Europe and North America, after lung cancer (Jemal et al., 2007). In the UK, approximately 34,500 new cases of colorectal cancer and 16,200 deaths were registered in 2001 (Cancer Research UK, 2005). This equates to 1 death in the UK from colorectal cancer every 32 minutes. About...
1 Sep 2017 to 31 May 2019
BETA is the next generation of radiofrequency ablation medical device, providing a minimally invasive method for destroying cancerous tissue. It will revolutionise the approach to non-resectable liver metastases, allowing for the non-invasive treatment of large volume with low recurrence risk within patients. BETA is the result of 10 years of academic res...
